We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Johns Hopkins Launches New COVID-19 Testing Insights Initiative

By LabMedica International staff writers
Posted on 09 May 2020
Print article
Image: Johns Hopkins Launches New COVID-19 Testing Insights Initiative (Photo courtesy of Johns Hopkins University)
Image: Johns Hopkins Launches New COVID-19 Testing Insights Initiative (Photo courtesy of Johns Hopkins University)
Johns Hopkins University (Baltimore, MD, USA) has launched the COVID-19 Testing Insights Initiative, a one-stop resource hub that fills the void of publicly-available information about COVID-19 testing data and offers critical insights, resources, and expert analysis about COVID-19 testing in the US.

In the coming weeks and months, viral tests for the presence of COVID-19 infection as well as serological tests for antibodies and possible immunity will be critical to measure the spread of the disease. Governments, businesses, and families will rely on data from these tests as well as answers to questions about testing capacity as they make decisions about the path forward. However, local testing data are not currently publicly available, and a comprehensive set of these data—paired with expert analysis and guidance—does not exist in one place. The Testing Insights Initiative aims to fill this void.

Through dynamic, continuously updated data visualizations, the Testing Insights Initiative offers a new, intuitive way to view and understand key data and insights to inform public policies and responses to the pandemic. The new initiative will be housed on the existing Johns Hopkins Coronavirus Resource Center webpage, an established resource for the public, policymakers, and the media about COVID-19 that has been viewed more than 400 million times in less than two months and linked to by more than 8,000 other websites.

Visualizations will chart trends in the data and measure testing capacity and results, as well as the efficacy of policy responses in real time. The new initiative will include COVID-19 testing trends for each US state, a tracker following the development and approval of serology tests, and frequently asked questions about COVID-19 testing. Following the initiative's launch, the site will quickly expand to include analyses of countries around the world. The site will be continuously updated as new data become available.

"Through the COVID-19 Testing Insights Initiative, Johns Hopkins will provide the comprehensive view of the testing landscape needed to guide effective policy decisions and shape our collective path to recovery," said Ron Daniels, president of Johns Hopkins University.

"The development and implementation of viral and serological tests are only half the battle," said Jennifer Nuzzo, senior scholar at the Johns Hopkins Center for Health Security and an associate professor at the Johns Hopkins Bloomberg School of Public Health. "The data from these tests must play a large role in decisions about our future, yet a complete set of these data are not currently publicly available. This initiative will fill that gap and provide essential insights to the public health community."

Related Links:
Johns Hopkins University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
SARS-CoV-2 Test
One Step SARS-CoV-2 Nucleic Acid Detection Kit (P761H)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: A false color scanning election micrograph of lung cancer cells grown in culture (Photo courtesy of Anne Weston)

AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell

Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.